Acrivastine and pseudoephedrine and Polatuzumab Vedotin-piiq
Determining the interaction of Acrivastine and pseudoephedrine and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Polio vaccine, inactivated
- Acrivastine and pseudoephedrine-Poliovirus Vaccine (Inactivated)
- Acrivastine and pseudoephedrine-Poliovirus vaccine, inactivated Injection
- Acrivastine and pseudoephedrine-Polivy
- Acrivastine and pseudoephedrine-Polmon
- Acrivastine and pseudoephedrine-Polocaine
- Polatuzumab Vedotin-piiq-Actamin
- Polatuzumab Vedotin-piiq-Actamin Maximum Strength
- Polatuzumab Vedotin-piiq-Actemra
- Polatuzumab Vedotin-piiq-Actemra (Tocilizumab (Intravenous))
- Polatuzumab Vedotin-piiq-Actemra (Tocilizumab Auto-Injectors)
- Polatuzumab Vedotin-piiq-Actemra (Tocilizumab Prefilled Syringes)